Remove Cardiology Remove Life Science Remove Nurses Remove Regulation
article thumbnail

“Nothing scares us” – Ukraine’s clinical research sector begins fearless recovery

Drug Discovery World

It was a subject of intense ethical debate whether life sciences companies should join other industries in leveraging sanctions against Russia, though many issued statements to say they had ceased clinical trial activity in the country. Russia invaded Ukraine on February 24, 2022. Karpenko echoes this sentiment. “We

article thumbnail

Cardiac Biomarkers in Cardiovascular Clinical Trials: Caveats and Considerations

XTalks

This is a part of the precision cardiology approach and could lead to their use as prognostic indicators. Liz Moore, DNP, advanced clinical nurse practitioner at Medpace, says that until the future of cardiac biomarkers arrives, CV clinical trials will have to continue to include and learn from the current markers.